Skip to main content

View full-text article in PMC

. 2022 Nov 1;36:03946320221137435. doi: 10.1177/03946320221137435

Table 2.

Effect of Lut/ZnO NPs on hepatic oxidative stress status.

Groups	Parameters
Groups	MDA (nmol/g tissue)	GSSG (nmol/g tissue)	GSH (nmol/g tissue)	PON1 (U/mg tissue)
Control	38.2 ± 2.7^a,b,c	42.1 ± 1.4^a,b,c	97.2 ± 1.4b^a,b,c	63.37 ± 2.1^a,b,c
Lut/ZnO NPs	32.7 ± 1.7^b,c,d	36.3 ± 2.3^b,c,d	107.5 ± 1.5^b,c,d	73.35 ± 1.5^b,c,d
HFD	104.6 ± 5.8^a,d,c	93.7 ± 1.9^a,d,c	48.8 ± 2.9^a,d,c	39.25 ± 1.3^a,d,c
HFD+STZ	129.1 ± 3.0^a,b,d	103.5 ± 3.7^a,b,d	32.1 ± 1.3^a,b,d	27.82 ± 2.6^a,b,d
HFD+Lut/ZnO NPs	68.1 ± 3.9^a,b,c,d	63.6 ± 3.7^a,b,c,d	74.9 ± 1.6^a,b,c,d	52.8 ± 1.0^a,b,c,d
HFD+STZ+Lut/ZnO NPs	77.5 ± 4.2^a,b,c,d	58.7 ± 1.8^a,b,c,d	64.6 ± 2.1^a,b,c,d	55.75 ± 1.2^a,b,c,d

Values were expressed as Means ± SE (n = 6).

^adenote significant change versus Lut/ZnO NPs.

^bdenote significant change versus HFD.

^cdenote significant change versus HFD+STZ at p < 0.05.

^ddenote significant change versus control.